CAI:RMDA (Egypt)
Â
Ordinary Shares
E£
2.35
(+9.3%)
May 27
Current and historical daily PE Ratio for Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (
CAI:RMDA
) from 2019 to May 28 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents stock (CAI:RMDA) PE ratio as of May 28 2024 is 16.43.
More Details
Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) PE Ratio (TTM) Chart
Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) PE Ratio (TTM) Historical Data
View and export this data going back to 2019. Start your Free Trial
Total 1163
- 1
- 2
- 3
- 4
- 5
- 6
- 13
| Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-28 | 16.4 | 2024-03-26 | 18.7 |
| 2024-05-27 | 16.4 | 2024-03-25 | 19.2 |
| 2024-05-26 | 15.0 | 2024-03-24 | 19.0 |
| 2024-05-23 | 15.0 | 2024-03-21 | 19.3 |
| 2024-05-22 | 14.8 | 2024-03-20 | 18.9 |
| 2024-05-21 | 15.0 | 2024-03-19 | 17.5 |
| 2024-05-20 | 15.0 | 2024-03-18 | 17.3 |
| 2024-05-19 | 15.3 | 2024-03-17 | 19.5 |
| 2024-05-16 | 14.3 | 2024-03-14 | 18.9 |
| 2024-05-15 | 13.8 | 2024-03-13 | 17.5 |
| 2024-05-14 | 13.9 | 2024-03-12 | 17.7 |
| 2024-05-13 | 13.9 | 2024-03-11 | 18.3 |
| 2024-05-12 | 13.8 | 2024-03-10 | 18.5 |
| 2024-05-09 | 14.2 | 2024-03-07 | 18.6 |
| 2024-05-08 | 14.4 | 2024-03-06 | 18.4 |
| 2024-05-07 | 14.6 | 2024-03-05 | 19.6 |
| 2024-05-06 | 14.5 | 2024-03-04 | 19.3 |
| 2024-05-05 | 14.5 | 2024-03-03 | 19.1 |
| 2024-05-02 | 14.5 | 2024-02-29 | 19.3 |
| 2024-05-01 | 14.4 | 2024-02-28 | 19.3 |
| 2024-04-30 | 14.4 | 2024-02-27 | 19.6 |
| 2024-04-29 | 15.0 | 2024-02-26 | 20.9 |
| 2024-04-28 | 14.4 | 2024-02-25 | 22.0 |
| 2024-04-25 | 15.5 | 2024-02-22 | 20.1 |
| 2024-04-24 | 15.5 | 2024-02-21 | 20.5 |
| 2024-04-23 | 16.6 | 2024-02-20 | 19.6 |
| 2024-04-22 | 17.6 | 2024-02-19 | 17.3 |
| 2024-04-21 | 17.8 | 2024-02-18 | 18.7 |
| 2024-04-18 | 17.4 | 2024-02-15 | 18.7 |
| 2024-04-17 | 18.3 | 2024-02-14 | 17.7 |
| 2024-04-16 | 18.5 | 2024-02-13 | 17.1 |
| 2024-04-15 | 18.3 | 2024-02-12 | 15.3 |
| 2024-04-14 | 17.9 | 2024-02-11 | 16.1 |
| 2024-04-11 | 17.9 | 2024-02-08 | 16.2 |
| 2024-04-10 | 17.9 | 2024-02-07 | 14.7 |
| 2024-04-09 | 17.9 | 2024-02-06 | 15.0 |
| 2024-04-08 | 17.9 | 2024-02-05 | 15.4 |
| 2024-04-07 | 18.0 | 2024-02-04 | 15.8 |
| 2024-04-04 | 18.4 | 2024-02-01 | 13.4 |
| 2024-04-03 | 18.2 | 2024-01-31 | 13.0 |
| 2024-04-02 | 18.6 | 2024-01-30 | 14.5 |
| 2024-04-01 | 18.9 | 2024-01-29 | 13.3 |
| 2024-03-31 | 18.2 | 2024-01-28 | 12.5 |
| 2024-03-28 | 18.9 | 2024-01-25 | 12.5 |
| 2024-03-27 | 19.1 | 2024-01-24 | 12.5 |
Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents
ISIN : EGS381B1C015
Share Class Description:
CAI:RMDA: Ordinary SharesCompare
Compare
Traded in other countries / regions
RMDA.Egypt IPO Date
2019-11-27Description
Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents is a pharmaceutical company. The company is engaged in the manufacturing, marketing, selling, and storage of pharmaceutical reagents for both human and veterinary use. It is also involved in manufacturing, marketing, selling, and storing diagnostic and pharmaceutical reagents for human, veterinary, and diagnostic use.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers